title: Bilateral Ischemic Retinal Vasculitis in Metastatic Cutaneous Melanoma Patient Treated with Dabrafenib and Trametinib: A Case Report.
authors.affiliation: a Eye Clinic, Department of Medical Sciences, Neuroscience and Sense Organs, University of Bari 'Aldo Moro,' , Bari , Italy.
authors.forename: Alfredo
authors.initials: A
authors.lastname: Niro
authors.affiliation: a Eye Clinic, Department of Medical Sciences, Neuroscience and Sense Organs, University of Bari 'Aldo Moro,' , Bari , Italy.
authors.forename: Nicola
authors.initials: N
authors.lastname: Recchimurzo
authors.affiliation: a Eye Clinic, Department of Medical Sciences, Neuroscience and Sense Organs, University of Bari 'Aldo Moro,' , Bari , Italy.
authors.forename: Alessandra
authors.initials: A
authors.lastname: Sborgia
authors.affiliation: b Department of Medical Oncology , National Institute of Cancer 'Giovanni Paolo II ,' Bari , Italy.
authors.forename: Michele
authors.initials: M
authors.lastname: Guida
authors.affiliation: a Eye Clinic, Department of Medical Sciences, Neuroscience and Sense Organs, University of Bari 'Aldo Moro,' , Bari , Italy.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Alessio
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005260:Female; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D007511:Ischemia / Q000139:chemically induced* / Q000175:diagnosis; D048369:MAP Kinase Kinase 1; D008545:Melanoma / Q000150:complications* / Q000188:drug therapy / Q000556:secondary; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010091:Oximes / Q000009:adverse effects*; D048493:Proto-Oncogene Proteins B-raf; D011728:Pyridones / Q000009:adverse effects*; D011744:Pyrimidinones / Q000009:adverse effects*; D031300:Retinal Vasculitis / Q000139:chemically induced* / Q000175:diagnosis; D012171:Retinal Vessels / Q000000981:diagnostic imaging*; D012878:Skin Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000556:secondary; D000096142:Cutaneous Malignant Melanoma
chemical_list: D000970:Antineoplastic Agents; D007093:Imidazoles; D010091:Oximes; D011728:Pyridones; D011744:Pyrimidinones; C560077:trametinib; D048493:Proto-Oncogene Proteins B-raf; D048369:MAP Kinase Kinase 1; C561627:dabrafenib